BioCentury
ARTICLE | Clinical News

Birinapant: Phase Ib/IIa data

July 1, 2013 7:00 AM UTC

Data from 51 evaluable patients with relapsed or refractory metastatic colorectal cancer (mCRC) in an open-label, U.S. Phase Ib/IIa trial showed that once-weekly IV birinapant plus irinotecan for the ...